Breast and Cervical Cancer Press Releases
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023.
BISMARCK, N.D. -- As North Dakota legislators close their first week of business for the new year, American Cancer Society Cancer Action Network advocates on Monday will ask them to take strong action to reduce the cost of fighting cancer.
As the Colorado General Assembly convenes for its 75th regular session on Wednesday, the American Cancer Society Cancer Action Network (ACS CAN) and its team of advocates is calling on legislators to support several priorities to improve the prevention, early detection and treatment of cancer.
Legislation will eliminate costly barriers to follow up breast cancer screening
S.2971, An Act relative to medically necessary breast screenings and exams for equity and early detection requires that health plans regulated by the Commonwealth cover medically necessary screening and diagnostic breast imaging with no out- of-pocket costs.
The American Cancer Society (ACS) released an update this week on breast cancer occurrence and trends in the United States. While the new report finds mortality rates have dropped by 44% since 1989, not all women have benefited from this progress. The report highlighted a continued upward trend in breast cancer incidence with the steepest increase in women younger than 50 years and Asian American/Pacific Islander (AAPI) women of all ages. The release coincides with the American Cancer Society Cancer Action Network’s (ACS CAN) campaign to connect patients with the right treatment at the right time through increasing access to biomarker testing in Hawaii.
Washington, D.C., – Emily Kalmer was recognized as the country’s top government relations professional by the American Cancer Society Cancer Action Network (ACS CAN) in honor of her exceptional work advocating for cancer-fighting public policies.
This week, the U.S. Senate Committee on Appropriations considered and approved its draft FY25 appropriations bill that includes significant increases for the NIH, increases for NCI and an increase for CDC's Division of Cancer Prevention and Control.
